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ABSTRACT Exported proteins of bacterial pathogens function both in essential
physiological processes and in virulence. Past efforts to identify exported proteins
were limited by the use of bacteria growing under laboratory (in vitro) conditions.
Thus, exported proteins that are exported only or preferentially in the context of in-
fection may be overlooked. To solve this problem, we developed a genome-wide
method, named EXIT (exported in vivo technology), to identify proteins that are ex-
ported by bacteria during infection and applied it to Mycobacterium tuberculosis dur-
ing murine infection. Our studies validate the power of EXIT to identify proteins ex-
ported during infection on an unprecedented scale (593 proteins) and to reveal in
vivo induced exported proteins (i.e., proteins exported signiﬁcantly more during in
vivo infection than in vitro). Our EXIT data also provide an unmatched resource for
mapping the topology of M. tuberculosis membrane proteins. As a new approach for
identifying exported proteins, EXIT has potential applicability to other pathogens
and experimental conditions.
IMPORTANCE There is long-standing interest in identifying exported proteins of
bacteria as they play critical roles in physiology and virulence and are commonly im-
munogenic antigens and targets of antibiotics. While signiﬁcant effort has been
made to identify the bacterial proteins that are exported beyond the cytoplasm to
the membrane, cell wall, or host environment, current methods to identify exported
proteins are limited by their use of bacteria growing under laboratory (in vitro) con-
ditions. Because in vitro conditions do not mimic the complexity of the host environ-
ment, critical exported proteins that are preferentially exported in the context of in-
fection may be overlooked. We developed a novel method to identify proteins that
are exported by bacteria during host infection and applied it to identify Mycobacte-
rium tuberculosis proteins exported in a mouse model of tuberculosis.
KEYWORDS beta-lactamase reporter, EXIT, Mycobacterium tuberculosis, in vivo,
membrane proteins, protein export, protein secretion, virulence
The bacterial exportome is the subset of proteins that are exported beyond thecytoplasm to the cytoplasmic membrane or the cell wall (CW) or are released
(secreted) into the environment. There is long-standing interest in identifying exported
proteins of bacteria as they play critical roles in physiology and virulence and are
commonly immunogenic antigens and targets of antibiotics (1, 2). However, current
approaches to identify exported proteins have limitations. Bioinformatic predictions of
exported proteins are complicated by disagreement between prediction algorithms,
which makes experimental validation critical. Mass spectrometry (MS)-based proteom-
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ics suffers from the intrinsic difﬁculty of isolating pure subcellular fractions, which can
result in identiﬁcation of contaminating proteins as false positives (3, 4). Genetic
reporters (e.g., PhoA) of export nearly always require phenotypic screening of in-frame
fusion proteins on a colony-by-colony basis, which limits the number of proteins
identiﬁed, even in the most ambitious efforts (5–7). A further signiﬁcant limitation of
current methods is their use of bacteria grown in laboratory media (in vitro), which fails
to recapitulate the complexity of the host environment (4). Thus, proteins that are
preferentially or exclusively exported during infection are overlooked (8). The signiﬁ-
cance of studying pathogens in the context of the host is borne out by methods such
as IVET (in vivo expression technology), STM (signature tagged mutagenesis), and TraSH
(transposon site hybridization), which reveal virulence mechanisms overlooked by in
vitro-based studies (9). Here, we report a novel genome-wide method that we refer to
as EXIT (exported in vivo technology) that identiﬁes proteins exported by a bacterial
pathogen during in vivo infection.
EXIT utilizes the ‘BlaTEM -lactamase reporter of export (10). Because ‘BlaTEM lacks
its native signal peptide for export, it is exported only to the extracytoplasmic space
when fused in-frame to an export signal (i.e., signal peptide or transmembrane do-
main). When exported, ‘BlaTEM cleaves -lactams and confers -lactam resistance to
bacteria (10). Importantly, ‘BlaTEM is a selectable reporter and bacteria exporting
‘BlaTEM can be collected by virtue of their ability to survive -lactam treatment. ‘BlaTEM
reporter fusions can identify cell wall and fully secreted proteins, as well as exported
domains of integral membrane proteins (10, 11) (Fig. 1a).
Here, we used EXIT to identify ‘BlaTEM fusions to proteins that are exported by the
pathogen Mycobacterium tuberculosis during infection of -lactam-treated mice. By
combining a comprehensive library of in-frame ‘BlaTEM fusions with the ability to select
bacteria exporting fusion proteins in vivo and next-generation sequencing en masse of
the recovered fusions, EXIT identiﬁed 593 proteins as exported byM. tuberculosis during
infection. This list of EXIT proteins is signiﬁcant in demonstrating in vivo export for 54%
of the 1,040 M. tuberculosis open reading frames (ORFs) computationally predicted to
be exported (see Materials and Methods). Moreover, for 100 proteins, EXIT provided the
ﬁrst experimental evidence for their export. EXIT also identiﬁed 32 proteins lacking in
silico predicted export signals, which speaks to the unbiased nature of the approach.
For the 337 integral membrane proteins identiﬁed, the sites of exported fusions are
signiﬁcant in providing protein topology information, which is notoriously difﬁcult to
predict computationally (12) but critical for membrane protein studies. Finally, 38 of the
proteins identiﬁed were in vivo induced exported proteins (i.e., proteins exported
signiﬁcantly more during in vivo infection than in vitro). We showed that M. tuberculosis
mutants defective in four of these proteins, all of unknown function, have intracellular
growth defects in macrophages. Our studies validate the power of EXIT to identify
proteins exported during infection, to reveal new virulence factors, and to provide
valuable resources for functional studies of uncharacterized proteins.
RESULTS
EXIT involves four steps (Fig. 1b; see Materials and Methods for details). In step 1, a
comprehensive library of plasmids carrying random fragments of M. tuberculosis
genomic DNA cloned in front of ‘blaTEM was constructed. On average, the M. tubercu-
losis EXIT library contained a fusion junction every 26 bp in the genome and each gene
was represented by 16 in-frame fusions. Because M. tuberculosis has an endogenous
-lactamase BlaC (13), the EXIT library was constructed in a M. tuberculosis blaC
mutant to enable selection for -lactam-resistant fusions. In step 2, mice were infected
with the pooled EXIT library and, starting 1 day after infection, treated with -lactam
antibiotics to select for M. tuberculosis exporting ‘BlaTEM fusion proteins in vivo. The
efﬁcacy of the -lactam treatment in selecting strains expressing exported ‘BlaTEM
fusions from a mixed population was initially conﬁrmed in proof-of-principle experi-
ments (see Fig. S1 in the supplemental material). After 2 weeks of treatment, mice were
sacriﬁced, and spleens and lungs were harvested. In step 3, organ homogenates were
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plated on 7H10 agar to recover M. tuberculosis clones that survived -lactam treatment
during infection. In step 4, library plasmids were isolated from the bacteria that survived
in vivo -lactam treatment, as well as from the input library, and the fusion junctions
were sequenced using next-generation sequencing. A pipeline was built to analyze the
sequencing data, and the abundance of individual fusions was determined by read
count. Using statistical modeling, highly abundant fusions recovered from the mice
following in vivo -lactam treatment were identiﬁed.
EXIT in M. tuberculosis-infected mice. EXIT experiments were performed in dupli-
cate on two independent occasions, with the results from each experiment being
highly correlated (Fig. S2A to C). As done before in genome-wide screens of M. tuber-
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FIG 1 (a) The ‘BlaTEM reporter. The ‘BlaTEM reporter is compatible with proteins localized to the
bacterial cytoplasmic membrane or cell wall or secreted from the bacterial cell. The right panel indicates
in-frame fusions to categories of exported proteins that confer -lactam resistance (red). In-frame fusions
to cytoplasmic proteins or the cytoplasmic domain of integral membrane proteins (purple) do not confer
-lactam resistance. (b) EXIT strategy. In step 1, a comprehensive library of 5  106 plasmids containing
fragments of M. tuberculosis (Mtb) genomic DNA fused to the ‘blaTEM reporter was constructed. The
plasmid library was transformed into the blaC -lactamase-sensitive mutant of M. tuberculosis, and 5 
106 transformants were pooled to generate the EXIT library. In step 2, mice were infected by intravenous
injection with the EXIT library and treated with -lactam antibiotics (oral gavage twice daily) to select for
EXIT clones exporting ‘BlaTEM fusion proteins. -lactam treatment began 1 day after infection and
continued to 2 weeks after infection. Mice were sacriﬁced, and spleens and lungs were harvested and
homogenized. In step 3, organ homogenates were plated on 7H10 agar and grown to recover M. tu-
berculosis clones that survived -lactam treatment during infection. Plates were scraped, and colonies
were pooled separately for lungs and spleens. In step 4, plasmids from the recovered bacteria and the
input samples were isolated and the fusion junction was sequenced using next-generation sequencing.
Sequencing primers were designed to read out of the ‘blaTEM reporter and sequence the immediately
adjacent M. tuberculosis DNA. Sequences were aligned to the M. tuberculosis genome. Unique sequences
were counted to identify the abundance of each fusion junction site within the population. The genes
that were most highly abundant after in vivo -lactam treatment were identiﬁed, and the results
corresponded to plasmids producing in-frame exported ‘BlaTEM fusion proteins.
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culosis in vivo (14–16), in order to achieve maximal library representation we infected
mice with the EXIT library using intravenous (i.v.) injection (~106 CFU), which resulted
in higher seeding of spleens versus lungs. Unless noted otherwise, the results described
are from the more comprehensive spleen data set. On the basis of proof-of-principle
experiments (Fig. S1), M. tuberculosis clones expressing in-frame ‘BlaTEM fusions to
ORFs of exported proteins were expected to survive and replicate during in vivo
-lactam treatment and to be more abundant (assessed by sequenced read count) than
strains not exporting the reporter in the output from treated mice. A Gaussian mixture
model was constructed to describe the data as two populations of low-abundance and
high-abundance genes (Fig. 2a). Using this statistical model, 593 genes were identiﬁed
as highly abundant (in both of the replicate experiments) in the recovered population
after in vivo -lactam treatment and were thus predicted to encode exported proteins
(see Table S1 in the supplemental material). For 82% of these 593 proteins, multiple
unique fusion sites were enriched after passage through -lactam-treated mice, pro-
viding conﬁdence in the list of proteins identiﬁed as exported in vivo (Fig. 2b; Table S1).
Note that there is no promoter sequence upstream of the reporter on the EXIT plasmid
backbone (pDW31); therefore, an active ‘BlaTEM fusion requires in-frame fusion to a
gene encoding an exported protein that is expressed from its native promoter.
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FIG 2 EXIT identiﬁed 593 proteins as exported during murine infection. (a) The most abundant fusion site within
each annotated gene in the M. tuberculosis genome was identiﬁed individually within the output for each of two
replicate experiments. The lower of these two numbers was plotted on a histogram. A two-component Gaussian
mixture model (black line overlay) was used to generate a statistical model distinguishing between high-
abundance genes (right) and low-abundance genes (left), with a statistical cutoff of log10  2.90 (red line). A total
of 593 genes were identiﬁed in the high-abundance population corresponding to EXIT exported proteins. (b) Genes
identiﬁed as encoding exported proteins were analyzed for the number of statistically enriched unique fusion sites
after in vivo -lactam treatment. On average, 4 unique fusion sites were enriched for each exported protein.
Percentiles are shown with dotted lines representing the 25th and 75th percentiles and a solid line representing
the 50th percentile. (c) The input EXIT library was composed of fusions in 99% of M. tuberculosis genes, with 74%
encoding proteins with no predicted export signal (yellow), 15% encoding predicted integral membrane proteins
(blue), and 11% encoding proteins containing predicted signal peptides (black). In contrast, 95% of the proteins
in the EXIT output contained an export signal. The 593 proteins identiﬁed as exported in EXIT were composed of
57% predicted integral membrane proteins (blue), 38% proteins containing a predicted signal peptide (black),
and 5% proteins with no predicted export signal (yellow). By analysis of all ORFs of M. tuberculosis H37Rv for
in silico predicted export signals (see Materials and Methods), 26% (1,040 proteins) of the M. tuberculosis
proteome were predicted to be exported. This compares well to predictions of exported proteins in other
bacteria, which usually predict 20% to 30% of the proteome to be exported (77).
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Validation of EXIT-identiﬁed proteins. We assessed the accuracy of EXIT to select
for in vivo exported proteins by searching for in silico predicted export signals (signal
peptides and transmembrane domains) in the proteins identiﬁed (Fig. 2c). A total of
95% of the 593 proteins had export signals compared to only 26% of in-frame fusions
in the input library. EXIT proteins with predicted Sec signal peptides, Tat signal
peptides, lipoprotein signal peptides, and transmembrane domains were identiﬁed
(Table S1). We also compared the proteins in the EXIT list to proteins previously
demonstrated to be exported by in vitro-grown bacteria using MS-based subcellular
proteomics or genetic reporters of export (Table S1). A total of 83% of EXIT proteins
were previously identiﬁed as exported, providing further validation. For the remaining
17% (100 proteins), the identiﬁcation by EXIT is signiﬁcant in providing the ﬁrst
experimental evidence of their export.
EXIT proteins lacking conventional signals for export. A small number of EXIT
proteins (32 proteins) lack predicted signal peptides or transmembrane domains. These
proteins are candidates for being nonconventional exported proteins or for being
overlooked by the in silico algorithms used (see Materials and Methods) (Fig. 2c)
(Table S2). To validate proteins on this list of unpredicted exported proteins, we used
the hsp60 promoter to constitutively express three of these proteins (Rv1728c, Rv3707c,
and Rv3811) with a C-terminal hemagglutinin (HA) tag in M. tuberculosis. Subcellular
fractions (cell wall, membrane, and soluble cytoplasm) prepared from these strains
were then used to localize these proteins by immunoblotting. All three proteins were
exported to the cell wall (CW) of M. tuberculosis (Fig. 3). These results conﬁrm the ability
of EXIT to identify exported proteins that are missed by heavily relied upon in silico
prediction tools.
EXIT fusions in the lungs. As a consequence of low seeding ofM. tuberculosis to the
lungs following i.v. injection (17), we were unable to develop a formal statistical model
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FIG 3 Validation of EXIT-identiﬁed exported proteins with no in silico predicted export signal. Three
proteins with no in silico predicted export signal (Rv1728c, Rv3707c, and Rv3811) were engineered with
C-terminal HA tags and expressed from the constitutive hsp60 promoter in M. tuberculosis. Cells were
irradiated, lysed by the use of a French pressure cell into whole-cell lysate (WCL), equalized by
bicinchoninic acid (BCA) protein quantiﬁcation, and fractionated by differential ultracentrifugation into
cell wall (CW), membrane (MEM), and soluble/cytoplasmic (SOL) fractions. Fractions derived from
equivalent amounts of starting cellular material were separated by SDS-PAGE, and HA-tagged proteins
were detected by immunoblotting performed with anti-HA antibodies. The cell wall protein (HbhA),
membrane protein (19-kDa lipoprotein), and cytoplasmic protein (SigA) were included as fractionation
controls.
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to analyze the lung data. However, using a threshold cutoff of 3.5-fold enrichment of
a gene in the lungs in both experimental replicates versus the input abundance (a
threshold which agreed with the statistically deﬁned threshold determined in the
spleens), we identiﬁed 282 proteins as strong candidates for being exported in the
lungs (Table S1). Of these, 274 (97%) were also on the list of 593 EXIT proteins exported
in the spleen (Table S1). We predict that bottleneck effects prevented us from identi-
fying a higher proportion of the 593 proteins as being exported in the lungs.
Eight proteins predicted to be exported in the lung, but not identiﬁed by EXIT as
exported in the spleen, represent a potentially interesting group of proteins that may
be regulated by the lung environment in either expression or export (Table S3). Four of
these proteins are PE_PGRS proteins, a poorly understood class of repeat-containing
proteins unique to mycobacteria (18). One of these proteins is PE_PGRS33, which
contributes to M. tuberculosis entry into macrophages (19) and may additionally
modulate the host cytokine response (18, 20). However, further studies will be required
to conﬁrm that these eight proteins are lung speciﬁc.
EXIT-exported fusions provide topology information for membrane proteins.
Because ‘BlaTEMmust be positioned in the extracytoplasmic space to produce -lactam
resistance, the behavior of individual EXIT fusions provides topological information. In
the 593 EXIT proteins, there were 2,516 fusion sites that were enriched during -lactam
treatment (from a total of 10,711 in-frame fusions for these proteins in the input)
(Table S1; Table S4). To validate the use of EXIT for topology mapping, we investigated
fusion sites in the MmpL3 transporter protein. All 13 of the MmpL3 EXIT fusions
enriched during -lactam treatment in vivo mapped to two large domains, indicating
an extracytoplasmic location, while other fusions in the input library, including many
that mapped to the C-terminus, were not enriched (Table S1; Table S4). These data align
with the TopPred (21) prediction of 12 transmembrane helices with two large extra-
cytoplasmic domains and a cytoplasmic C-terminus for MmpL3 (Fig. 4), and they agree
with results of recent MmpL3 structure and topology studies (22). Given that multiple
topology models have been published for MmpL3 (23–32) (Fig. S3), this analysis is
signiﬁcant in demonstrating the ability of EXIT to distinguish between discordant
models. Among 10 other MmpL proteins identiﬁed, there were 52 enriched EXIT fusion
sites that mapped similarly to two large domains, suggesting that these extracytoplas-
mic domains are a conserved feature of MmpL transporters (Table S1; Table S4).
Identiﬁcation of in vivo induced exported proteins. EXIT provides an opportunity
to identify M. tuberculosis proteins that are exported more during in vivo infection than
during in vitro growth. Such proteins, which we refer to as in vivo induced exported
proteins, could result from transcriptional/posttranscriptional induction in vivo or from
in vivo upregulation of the responsible protein export system. In either case, the in vivo
regulation is suggestive of important functions during infection. To identify in vivo
induced exported proteins, the EXIT bacteria surviving -lactam treatment in mice were
plated in parallel on 7H10 agar and 7H10 agar containing -lactam (Fig. 5a). The clones
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FIG 4 MmpL3 topology mapping using EXIT fusion site data. A total of 37 unique fusion sites in MmpL3 were
represented in the input library (black hexagons). Of these, 13 fusion sites were enriched during -lactam
treatment of mice, indicating an extracytoplasmic location (red hexagons) corresponding to two large exported
domains of the MmpL3 protein. Exported fusion sites were mapped onto the in silico topology prediction
generated by TopPred (21).
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recovered on regular agar represent the fusion proteins exported during infection (i.e.,
the 593 in vivo exported proteins discussed above). Clones recovered on -lactam agar
express fusions that are additionally expressed and exported under in vitro conditions.
There was high correlation in the abundances of individual EXIT fusions recovered from
7H10 agar with and without -lactam, indicating that the majority of EXIT proteins were
exported similarly in vivo and under these in vitro conditions (Fig. S2D). To identify
proteins that are exported signiﬁcantly more in vivo than in vitro, genes with signiﬁ-
cantly lower recovery from -lactam agar (in vitro plus in vivo) versus regular agar (in
vivo) were identiﬁed, a multiple-comparison correction was applied, and the false-
discovery rate (FDR) was set at 5% (see Materials and Methods). In this way, 38 of the
593 EXIT proteins were identiﬁed as in vivo induced exported proteins (Table 1)
(Fig. 5b). Of the 38 in vivo induced exported proteins, 14 were previously shown to be
transcriptionally upregulated during infection, which helps validate this approach
(Table 1). Proteins with functions in regulation (SenX3, PknH), host defense (MmcO,
Rv3654c), and cell wall lipid transport (DrrC, MmpL8) were among those identiﬁed.
However, the largest category of in vivo induced exported proteins (19 of 38 proteins)
consisted of proteins of unknown function. Another notable category of in vivo induced
exported proteins consists of proteins lacking in silico predicted export signals. Eight of
in vitro in vivoin vitro in vivo
in vitro in vivo
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FIG 5 Strategy for identiﬁcation of in vivo induced exported proteins. (a) Identiﬁcation of in vivo induced exported proteins.
Spleens from -lactam-treated mice infected with the EXIT library were harvested after 2 weeks of infection. Spleen
homogenates were plated in parallel on 7H10 agar without -lactam to recover all clones (red Venn diagram) and on 7H10
agar containing -lactam to recover clones exporting ‘BlaTEM fusion proteins during in vivo growth and in vitro growth (purple
Venn diagram). The population of clones identiﬁed only or in signiﬁcantly greater abundance on media lacking -lactams
represents proteins whose export was induced during infection (blue). (b) Sequenced read count values recovered from agar
with or without -lactam for the 593 EXIT proteins were plotted to compare abundances after -lactam treatment in vivo, with
the abundance after dual -lactam treatment in vivo and in vitro indicated. The majority of proteins identiﬁed as exported in
vivo remained highly abundant after additional -lactam treatment in vitro (black). A total of 38 genes (highlighted in red) were
identiﬁed as statistically less abundant after in vitro -lactam selection, representing proteins exported signiﬁcantly more in
vivo than in vitro (see Materials and Methods for details on statistical analysis). (c) In vivo induced exported proteins with roles
promoting growth in macrophages (rv1508::tn, rv3707c:tn, rv0559c::tn, and rv2536::tn). Murine bone marrow-derived macro-
phages were infected with M. tuberculosis CDC1551 transposon mutants lacking individual in vivo induced exported proteins.
At speciﬁc times postinfection, macrophage lysates were plated to measure intracellular CFU. The fold change in CFU over the
course of the infection is plotted relative to the bacterial burden at day 0 postinfection. Statistical signiﬁcance was determined
by one-way analysis of variance (ANOVA) with multiple comparisons performed by the use of the Holm-Sidak (normal by
Shapiro-Wilk) or Student-Newman-Keuls (nonnormal) test (*, P  0.05 [compared to wild-type {WT} CDC1551]). These data are
representative of results of four independent experiments, each performed with triplicate wells of infected macrophages. (d)
NarK3 and LipM [lipM::tn (rv2284::tn) and narK3::tn (rv0261c::tn)] mutants did not exhibit intracellular growth defects in
macrophages. NS, not signiﬁcant.
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the 38 in vivo induced exported proteins identiﬁed by EXIT lack predicted export
signals, including Rv3707c, which we conﬁrmed to have been exported to the cell wall
(Fig. 3).
In vivo induced exported proteins contribute toM. tuberculosis virulence. Given
the precedent for upregulation of virulence factors in the host (8), we predicted that the
list of in vivo induced exported proteins would include proteins with roles in patho-
genesis. In fact, 13 of the exported proteins on the list of those induced in vivo have
demonstrated or predicted roles (based on TraSH/transposon sequencing [Tnseq]
studies) in virulence (Table 1). To explore this possibility further, we obtained six
M. tuberculosis mutants with transposon insertions in genes encoding in vivo exported
proteins from the Biodefense and Emerging Infections Research Resources Repository
(BEI Resources) (33) and tested them for intracellular growth in murine bone marrow
macrophages. Intracellular growth of each mutant was compared to that of the
TABLE 1 In vivo induced exported proteins identiﬁed by EXIT
ORF no. Gene name(s) Predicted or proven function
In silico
export
signala
Predicted or proven
essential in vitro or
during infection
Transcriptional
upregulation in
vivo
q
value
Rv0011c Cell division TM 0.000
Rv0261c narK3 Nitrite extrusion protein TM 0.003
Rv0490 senX3 Two-component sensor histidine
kinase
TM In mice (14, 78, 79) 0.028
Rv0506 mmpS2 Unknown SP, TM 0.007
Rv0559c Unknown SP 0.008
Rv0593 lprL, mce2E Mce family lipoprotein Lipo, TM In mice (80) 0.006
Rv0615 Unknown TM 0.017
Rv0713 Unknown TM 0.001
Rv0817c Unknown SP, TM In vitro (81) 0.005
Rv0846c mmcO Multicopper oxidase SP, Tat SP,
Lipo
0.000
Rv0892 Probable monooxygenase TM In macrophages (82) 0.008
Rv1026 ppx-2 Polyphosphatase In vitro (81), in mice (83) 0.022
Rv1145 mmpL13a Unknown TM 0.000
Rv1266c pknH Serine/threonine-protein kinase TM In mice (84) 0.029
Rv1508c Unknown TM In mice (85) 0.007
Rv1517 Unknown Tat SP, TM 0.015
Rv1639c Unknown TM 0.007
Rv1737c narK2 Possible nitrate-nitrite transporter TM In mice (15) In macrophages (82) 0.000
Rv1739c Sulfate transporter TM In macrophages (82) 0.043
Rv1965 yrbE3B Permease component of Mce
system
TM In macaques (86), in mice
(87, 88)
In macrophages (82) 0.001
Rv1969 mce3D Mce family protein SP, TM In mice (87, 88) 0.006
Rv2138 lppL Probable conserved lipoprotein SP, Lipo, TM In mice (15), in vitro (81) 0.006
Rv2144c Unknown TM In mice (85) 0.001
Rv2273 Unknown TM In macrophages (89) 0.000
Rv2284 lipM Probable esterase TM In mice (90) 0.024
Rv2330c lppP Probable lipoprotein SP, Lipo, TM In macrophages (91) In macrophages (82) 0.007
Rv2380c mbtE Mycobactin synthesis In mice (15), in vitro (81) In macrophages (82) 0.007
Rv2536 Unknown TM In mice (15) 0.017
Rv2938 drrC Phthiocerol dimycocerosate
transport
TM In mice (15) 0.017
Rv3343c PPE54 PPE family protein In vitro (81) In humans (92) 0.006
Rv3478 PPE60, mtb39c PE family protein 0.017
Rv3526 kshA Oxygenase component of
3-ketosteroid-9-alpha-hydroxylase
In mice (93) In macrophages (82) 0.005
Rv3554 fdxB Possible electron transfer TM 0.001
Rv3596c clpC1 ATP-dependent protease ATP-
binding subunit
In macrophages (57, 91),
in vitro (81)
0.006
Rv3654c Unknown In macrophages (34) In humans (92) 0.000
Rv3701c Ergothioneine biosynthesis In macrophages (91), in
mice (14)
0.039
Rv3707c Unknown 0.039
Rv3823c mmpL8 Sulfolipid-1 (SL-1) transporter TM In mice (15), in vitro (81) 0.027
aLipo, lipoprotein signal peptide; SP, Sec signal peptide; Tat, Tat signal peptide; TM, transmembrane domain.
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parental M. tuberculosis CDC1551 strain by plating bacilli from macrophage lysates over
time. Mutants carrying transposon insertions in lipM and narK3 had no intracellular
growth defect in macrophages (Fig. 5d). However, four mutants carrying transposon
insertions in genes encoding in vivo induced exported proteins of unknown function
(rv3707c, rv1508c, rv0559c, and rv2536) demonstrated signiﬁcant defects in intracellular
growth compared to the parental strain (Fig. 5c). None of these mutants exhibited a
general growth defect during growth in culture (in vitro) (data not shown). This mutant
analysis demonstrates how the functional genomics information provided by EXIT can
be harnessed to reveal uncharacterized virulence factors.
DISCUSSION
EXIT is a method for discovering bacterial proteins exported during in vivo infection.
In applying this approach to M. tuberculosis, we identiﬁed an unprecedented total of
593 in vivo exported proteins and additionally identiﬁed in vivo induced exported
proteins that include uncharacterized virulence factors. Moreover, the total number of
EXIT proteins identiﬁed surpassed the number of exported proteins identiﬁed in past
discovery efforts using genetic reporters with in vitro-grown bacteria (5–7, 11). EXIT
increased the number of experimentally demonstrated M. tuberculosis exported pro-
teins by 100, including examples lacking in silico predicted export signals, and it
provided a database of enriched fusion sites for mapping protein topology. The broad
effectiveness of EXIT can be attributed to the following factors: (i) the highly compre-
hensive library (99% of the genome represented with at least one in-frame fusion); (ii)
the use of the ‘BlaTEM reporter as a selectable marker in vivo; and (iii) the use of
next-generation sequencing and statistical analysis to identify exported fusions.
EXIT identiﬁed 32 proteins that lack export signals, with 8 being in vivo induced
exported proteins. Although it remains possible that some of the EXIT protein identi-
ﬁcations represent false positives, our validation of three of these proteins as exported
(Fig. 3) argues for other proteins on this list being true exported proteins. EXIT
identiﬁcation of proteins lacking standard export signals may reﬂect the limitations of
in silico algorithms or reﬂect the fact that these proteins are exported by unconven-
tional pathways. For example, the in vivo induced exported Rv3654c protein lacks an
obvious export signal but was previously suggested to be secreted during infection, on
the basis of detection of Rv3654c in macrophage lysates (34). Our EXIT results provide
important conﬁrmation of Rv3654c being exported in vivo. Further, the rv3654c gene is
located near genes for potential tight adherence (Tad) secretion system components
(34), which could be responsible for Rv3654c export.
EXIT identiﬁed all types of exported proteins: cytoplasmic membrane proteins (e.g.,
MmpL3 [22], OmamA [35]), cell wall proteins (e.g., FbpA [36, 37], HbhA [38]), mycobac-
terial outer membrane proteins (e.g., OmpA [39], SpmT [40]), and fully secreted/
extracellular proteins (SapM [41], Mpt63 [42]) (see Table S1 in the supplemental
material). However, the small secreted ESAT-6/CFP-10-like proteins that are secreted by
specialized ESX/type VII secretion systems (43), and SodA and PknG, which require the
SecA2-dependent system for export, were not identiﬁed by EXIT (44–46), despite the
presence of in-frame fusions in the input library. For any genetic reporter of export,
some proteins may be missed due to incompatibility with specialized export systems;
for example, ESAT-6/CFP-10 proteins are secreted as a dimer (43) and one possibility is
that ‘BlaTEM fusions could disrupt ESAT-6/CFP-10 interactions. In addition, proteins may
be missed due to the level of expression required for a positive export signal (-lactam
resistance), toxicity, or instability of certain fusion proteins. One of these factors is the
likely explanation for the fact that no ESAT-6/CFP-10, SodA, or PknG proteins were
identiﬁed by the ‘BlaTEM reporter in EXIT or in our past studies (11). Note that a study
reporting the use of the ‘BlaTEM reporter with ESAT-6/CFP-10 secreted proteins was
retracted (47, 48). However, EXIT was successful in identifying other examples of
SecA2-dependent proteins (solute binding proteins and Mce proteins [45]), and it
identiﬁed 10 PE, PPE, and PE_PGRS proteins representing another protein family
exported by ESX/type VII secretion systems (49, 50). The YxxxD/E motif that exists in
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proteins exported by ESX/type VII secretion systems is present in 6 of the 10 EXIT-
identiﬁed PE, PPE, and PE_PGRS proteins, although some of these proteins additionally
have in silico predicted Sec signal peptides (Table S1; Table S3), which makes their route
of export more difﬁcult to predict.
As an unbiased genome-wide approach, EXIT has the potential to reveal unanno-
tated/misannotated proteins. Along these lines, EXIT identiﬁed multiple enriched fu-
sions in the same reading frame in six unannotated intragenic regions of the genome.
We hypothesize that these fusions map to unannotated ORFs (Table S5). For example,
a candidate unannotated ORF with a Sec signal peptide is in the region between
Rv2304c and Rv2305 (labeled as downstream of Rv2307c). Future studies are warranted
to conﬁrm the existence of these putative proteins.
Although protein topology is critical information for understanding membrane
protein function, limited experimental topology data exist on a genome-wide level and
the in silico prediction algorithms used to design experiments often disagree (12). EXIT
proved valuable in discriminating between topology predictions for MmpL3, a protein
of interest for its essentiality in M. tuberculosis and its association with resistance
mutations to several TB drug candidates (25–27, 32). We similarly investigated EXIT
fusions to Rv1002c, which O-mannosylates exported proteins and contributes to viru-
lence (51, 52). As with MmpL3, different prediction programs generate discordant
models for Rv1002c (see Fig. S3 in the supplemental material). In this case, of the ﬁve
models consulted, the HMMTOP prediction (53) was the best match as it positioned the
enriched EXIT fusions in two extracytoplasmic domains and the C-terminus (Fig. 4;
Fig. S3); this model was also the most similar to the topology of the homologous yeast
O-mannosyltransferase (54). It should be noted that our analysis did not identify any
one prediction program as being better than others overall, including TMHMM (55)
which is used on Tuberculist (56); rather, it emphasized the value of the EXIT data to
select the best model. For each of the 593 EXIT proteins, the site of enriched fusions to
the reporter as well as all the in-frame EXIT fusions in the input library are provided
(Table S1; Table S4). The list of total fusions will be useful for identifying nonenriched
fusions to predict cytoplasmic domains. However, there are alternate explanations
besides a cytoplasmic location for unenriched ‘BlaTEM fusions (e.g., unstable fusion
proteins). To deﬁnitively assign cytoplasmic domains will require testing fusions to
cytoplasmic reporters of protein topology.
For the 38 proteins identiﬁed as in vivo induced exported proteins (Table 1), the
combination of an exported location and host regulation makes them compelling
candidates for being virulence factors. Using bone marrow macrophages, we showed
that mutants of four of the in vivo induced exported proteins of unknown function
(Rv0559c, Rv1508c, Rv2536, and Rv3707c) are defective for intracellular growth in
macrophages. For Rv0559c and Rv1508c, this is the ﬁrst indication that they function in
M. tuberculosis virulence. For Rv2536, the protein is predicted by Tnseq to play a role
during murine infection (15); however, our data are the ﬁrst to suggest a speciﬁc role
promoting M. tuberculosis growth in macrophages. Lastly, while the Rv3707c homolog
in Mycobacterium bovis BCG is known to promote growth in macrophages (57), the
protein remains unstudied in M. tuberculosis. The speciﬁc functions of all four of these
in vivo induced proteins in macrophages remain a mystery and warrant further study.
Future studies should explore the other in vivo induced exported proteins for potential
virulence functions.
The list of in vivo induced exported proteins also sheds light on conditions encoun-
tered during infection that are not recapitulated during in vitro growth. For example,
the identiﬁcation of SenX3, a sensor histidine kinase of the SenX3-RegX3 two-
component system that responds to low phosphate levels (58, 59), suggests that
M. tuberculosis encounters phosphate-limiting conditions during murine infection. The
identiﬁcation of MmcO, a multicopper oxidase that protects against copper toxicity (60,
61), is consistent with M. tuberculosis experiencing a high-copper environment during
infection (62).
Past efforts to identify bacterial proteins exported during infection focused on direct
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testing of preselected proteins for secretion into cultured cells through microscopy or
subcellular fractionation (63–65). In comparison, EXIT provides a tool for large-scale
discovery of in vivo exported proteins. A recent MS-based proteomics approach for
identifying labeled bacterial proteins secreted into cultured cells holds promise as a
potential alternate discovery strategy (66). However, as with other proteomics studies
of secreted proteins, a challenge facing this new methodology is that of avoiding
identiﬁcation of cytoplasmic proteins released by unintended bacterial lysis (67).
In summary, here we introduce EXIT as an effective and robust method to identify
bacterial proteins exported in a whole-animal model of infection. For theM. tuberculosis
research community, the data generated during the course of this work represent a
valuable functional genomics resource for assigning function to uncharacterized pro-
teins. For the larger microbiology community, EXIT provides a method that could be
adapted to other bacterial pathogens. This study focused on application of EXIT during
acute murine infection with M. tuberculosis. However, the ‘BlaTEM reporter and EXIT
methodology are theoretically compatible with any bacterium that is either naturally
-lactam sensitive or can be made so genetically. In the future, EXIT could be used to
study the in vivo exportome of other pathogens or different stages of infection.
MATERIALS AND METHODS
Bacterial strains and growth. Bacterial strains and plasmids are listed in Table S6 in the supple-
mental material. M. tuberculosis strains were grown with Middlebrook 7H9 broth or 7H10 agar (Difco)
supplemented with 1 albumin dextrose saline (ADS), 0.5% glycerol, and 0.05% Tween 80 (7AGT) (68).
As needed, growth medium was supplemented with 20 g/ml kanamycin (Acros), 50 g/ml hygromycin
(Roche), or 50 g/ml carbenicillin (Sigma). Escherichia coli strains were grown on Luria-Bertani medium
(Fisher) supplemented as necessary with 40 g/ml kanamycin, 150 g/ml hygromycin, and 100 g/ml
carbenicillin.
EXIT library construction. M. tuberculosis genomic DNA (gDNA) was prepared as previously de-
scribed (69) from the M. tuberculosis ΔblaC mutant, named PM638 (13). Genomic DNA fragments
between 500 bp and 5 kb in size were generated by partial digestion with AciI and HpaII and cloned into
the multicopy, hygromycin-marked, EXIT library plasmid pDW31 (see Text S1 in the supplemental
material for pDW31 construction) using the unique ClaI site located immediately upstream of the ‘blaTEM
reporter. Ligated plasmids were transformed into MegaX DH10 electrocompetent cells (Invitrogen). E. coli
transformants (5.6  106) were pooled, and plasmids were isolated using a QiaFilter Plasmid Giga kit
(Qiagen). Plasmids isolated from E. coli were next transformed into PM638, M. tuberculosis H37Rv ΔblaC
(13), as previously described (68). M. tuberculosis transformants (5.4  106) from 50 transformations were
pooled to produce the input EXIT library used to infect mice. The input library was subjected to
next-generation sequencing using a primer at the fusion junction to ‘blaTEM (Table S6, primers). On
average, the library contained a fusion every 26 bp in the M. tuberculosis genome, with the largest
nonrepresented region of the genome being only 110 nucleotides long. The complexity of the library
was such that each gene was represented by an average of 16 in-frame fusions, and some genes
contained more than 35 in-frame fusions. A total of 99% of the genes in the M. tuberculosis genome were
represented by at least one in-frame fusion.
Mouse infection with the EXIT library. For each experiment, 8-to-10-week-old female BALB/c mice
were intravenously infected, as previously described (44), with 3  106 M. tuberculosis bacteria from the
EXIT library, of which approximately 20% seeded the spleen and 1% seeded the lungs (data not shown),
consistent with previous studies (17). For each experiment, 30 mice were infected. At 1 day after
infection, organs from six mice were harvested to determine the initial dose and organ burden. At 1 day
after infection, the remaining 24 mice began receiving treatment twice daily by oral gavage with 40 mg
amoxicillin (MP Biomedicals 190145 or Sigma A8523) and 8 mg probenecid (Sigma P8761) administered
in 0.25 M NaOH–phosphate-buffered saline (PBS). Probenecid, a synergistic drug, is used in conjunction
with amoxicillin to reduce drug efﬂux in the kidneys, increasing the serum concentration (70). The use
of 24 animals per experiment was based on calculations performed to achieve a 99.5% probability that
any individual clone in the EXIT library would establish infection in the spleen of at least one mouse in
each replicate experiment (by calculations using the binomial equation 1 P [Q]n, where n represents
the number of mice, Q represents the probability of failure in each individual mouse, and P represents
the probability of overall success). At 14 days postinfection, mice were euthanized, and spleens and lungs
were harvested to collect surviving bacteria. Organ homogenates were plated undiluted onto 7H10 agar.
These recovered fusions were used to identify in vivo exported proteins. For determining fusions
exported both in vivo and in vitro, organ homogenates were plated in parallel onto 7H10 agar containing
carbenicillin (a -lactam). Plates were incubated at 37°C for 3 weeks, after which colonies were pooled
for plasmid DNA isolation (see Text S1). All mice were maintained under speciﬁc-pathogen-free condi-
tions in a biosafety level 3 (BSL-3) facility. Mice were assigned randomly to experimental groups, and the
mouse studies were not performed in a blind fashion. All procedures involving the use of animals were
in compliance with protocols approved by the University of North Carolina Chapel Hill Institutional
Animal Care and Use Committee and Biosafety Committee.
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Next-generation sequencing, data analysis, and statistical modeling (see Text S1 for additional
details). Sample preparation and sequencing strategies for the ‘blaTEM fusion junction that includes
upstream M. tuberculosis genomic DNA are provided in Text S1. Samples were sequenced using
next-generation sequencing (Illumina HiSeq), generating paired-end multiplexed sequencing reads. To
identify fusion sites, reads were trimmed of adapter sequences and aligned to the H37Rv genome. For
statistical analysis, unique reads for each fusion site were counted using read counts that were ﬁrst
normalized to the total number of sequenced reads in each sample as follows. (i) To identify proteins
exported in vivo, fusions recovered on standard 7H10 agar from -lactam-treated mice (in vivo) were
subjected to statistical analysis. The most abundant fusion position within each annotated gene was
identiﬁed individually within the output for each of the two EXIT experiments. The lower of these two
numbers from comparisons between replicates was used as the abundance value for the gene to require
that any identiﬁed gene was highly abundant in both samples. Log10 values were used to generate a
histogram, which was bimodal. A Gaussian mixture model was then used to identify the mean and
variance for each population and to determine the probability that a fusion was in the higher-abundance
or lower-abundance population (Fig. 2a). The abundance levels in the unselected input library were
relatively uniform; thus, computation of enrichment ratios was not required and the statistical analysis
was done on the distribution of abundances. (ii) To identify the in vivo induced exported proteins, fusions
recovered on -lactam-containing agar (in vitro) were subjected to statistical analysis and, in this case,
the higher abundance value from comparisons between replicates was used as a representative
abundance value for the gene, to identify the most stringent list of proteins that were not exported in
vitro in either experiment. The log10 value of the ratio between the abundance seen following in vivo
treatment and that seen following in vivo plus in vitro treatment was calculated. The top and bottom 5%
were trimmed for robustness. These data ﬁt a normal unimodal distribution, where genes of interest had
high ratios of in vivo reads versus in vivo plus in vitro reads. A normal ﬁt distribution was used to identify
outliers, with higher ratios than would be predicted by chance. The Benjamini-Hochberg procedure was
used to correct for multiple comparisons and identiﬁed genes with a P value of 0.0005 (false-discovery
rate, 0.05). Corrected P values (q values) are reported (Table 1). (iii) To identify all individual enriched
fusion junctions in an ORF for topology determination, the number of reads for each fusion site in the
output from -lactam-treated mice was divided by the number of sequenced reads in the corresponding
input for each experiment. Log10 enrichment values were used to generate histograms, which produced
a unimodal distribution with a right shoulder of enriched sites. A Gaussian mixture model was ﬁtted to
the distribution using Mclust in R (71). The resulting mixture models had two peaks, one representing the
majority of the sites and a second, smaller peak representing points in the right shoulder representing
the enriched fusions. Fusion sites that were statistically enriched in both experiments were considered
to be exported.
Subcellular fractionation and immunoblotting. M. tuberculosis cells were pelleted by centrifuga-
tion, sterilized by irradiation (JL Shepherd Mark I-137Cs irradiator), and removed from BSL-3 containment.
Subcellular fractionation was performed by differential ultracentrifugation as previously described (35),
generating clariﬁed whole-cell lysates (WCL) and cell wall (CW), membrane (MEM), and soluble cytoplas-
mic (SOL) fractions. Fractions from equivalent original cell material were separated by SDS-PAGE and
transferred to nitrocellulose membranes. Proteins were detected using the primary anti-HA antibody
(Covance) (1:25,000), anti-SigA antibody (a gift from Murty Madiraju [72]) (1:20,000), 19kd (a gift from
Douglas Young, Imperial College London, United Kingdom) (1:20,000), and HbhA (BEI Resources [38])
(1:5,000) and secondary anti-mouse- and anti-rabbit-conjugated horseradish peroxidase (HRP) (Bio-Rad).
HRP signal was detected using an enhanced chemiluminescence kit (PerkinElmer).
Identiﬁcation of export signals. Sequences were analyzed for transmembrane domains and signal
peptides using TMHMM (55) and Signal P (73). Previous analyses of the M. tuberculosis genome
performed with LipoP, TatP, TATFIND, and TigrFAM were used to identify proteins with lipoprotein or Tat
signal peptides (74, 75). PE/PPE proteins were analyzed for YxxxD/E motifs (49).
Macrophage infections. The following reagents were obtained through BEI Resources, NIAID, NIH:
Mycobacterium tuberculosis strain CDC1551 transposon mutants (33) (Table S6). M. tuberculosis mutants
were validated by PCR and Southern blotting (data not shown). Bone marrow-derived macrophages were
isolated utilizing C57BL/6 mice as described previously (76). The macrophages were infected with
M. tuberculosis strains at a multiplicity of infection (MOI) of 1 for 4 h. After infection, the macrophages
were washed three times to remove extracellular bacteria. At time points postinfection, the macrophages
were lysed using 1% Triton X-100 (Sigma), and the lysates were diluted and plated for CFU determina-
tions on 7H10 (Difco) or 7H11 (Sigma) plates supplemented with 0.05% Tween 80, 0.5% glycerol, 1
albumin dextrose saline (ADS), and 20 g/ml kanamycin (Acros).
Data availability. Raw sequencing data will be made available upon request.
Code availability. The code developed for analyzing the sequencing data will be available through
GitHub (http://github.com/gomezlab/exit), a publicly available repository, under an open source license.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00333-17.
TEXT S1, DOCX ﬁle, 0.02 MB.
FIG S1, EPS ﬁle, 0.8 MB.
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Perkowski et al. ®
March/April 2017 Volume 8 Issue 2 e00333-17 mbio.asm.org 12
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
TABLE S1, DOCX ﬁle, 0.1 MB.
TABLE S2, DOCX ﬁle, 0.1 MB.
TABLE S3, DOCX ﬁle, 0.01 MB.
TABLE S4, DOCX ﬁle, 0.3 MB.
TABLE S5, DOCX ﬁle, 0.01 MB.
TABLE S6, DOCX ﬁle, 0.03 MB.
ACKNOWLEDGMENTS
We thank Scott Deaton for assistance with statistical analyses, Marcia Sanders and
the UNC Vironomics Core for assistance in sequencing for pilot studies, and Ellen Young
for support in the animal experiments. We thank Bill Goldman, Inna Krieger, Dirk
Dittmer, Chris Ford, and Sarah Fortune for helpful discussions. We thank Murty Madiraju
for providing the SigA antibody, Douglas Young for providing the 19-kDa antibody, and
Gyanu Lamichhane and BEI Resources for transposon mutants of Mycobacterium tuber-
culosis strain CDC1551. The following reagent was obtained through the NIH Biode-
fense and Emerging Infections Research Resources Repository, NIAID, NIH: monoclonal
anti-Mycobacterium tuberculosis HbhA (gene Rv0475), clone -HbhA (produced in vitro)
(NR-13804).
This work was supported by a Burroughs Wellcome Investigator in Pathogenesis of
Infectious Disease award and NIH grants R01AI054540 and AI070928 (to M.B.) and the
Welch Foundation (grant no. A-0015 to J.C.S.). E.F.P. was supported by a University of
North Carolina Dissertation Completion Fellowship.
E.F.P. and M.B. designed experiments and wrote the manuscript. E.F.P. conducted all
experiments except where noted below. D.W. constructed pDW31 and assisted with
construction of the library. J.D.H. assisted in transformation of the EXIT library into
M. tuberculosis and with murine experiments performed with the EXIT library. J.C.S. and
T.R.I. carried out Illumina sequencing, and T.R.I. performed statistical analysis of the EXIT
data set. D.O. and S.M.G. built the pipeline for analysis of the sequencing data. K.E.Z.
performed macrophage infection experiments and immunoblot fraction control exper-
iments.
REFERENCES
1. McCann JR, Kurtz S, Braunstein M. 2009. Secreted and exported proteins
important to Mycobacterium tuberculosis pathogenesis, p 265–298. In
Wooldridge K (ed), Bacterial secreted proteins: secretory mechanisms
and role in pathogenesis. Caister Academic Press, Norfolk, United King-
dom.
2. Jackson M, McNeil MR, Brennan PJ. 2013. Progress in targeting cell
envelope biogenesis in Mycobacterium tuberculosis. Future Microbiol
8:855–875. https://doi.org/10.2217/fmb.13.52.
3. Chandramouli K, Qian PY. 2009. Proteomics: challenges, techniques and
possibilities to overcome biological sample complexity. Hum Genomics
Proteomics 2009:239204. https://doi.org/10.4061/2009/239204.
4. de Souza GA, Wiker HG. 2011. A proteomic view of mycobacteria.
Proteomics 11:3118–3127. https://doi.org/10.1002/pmic.201100043.
5. Seo KS, Kim JW, Park JY, Viall AK, Minnich SS, Rohde HN, Schnider DR,
Lim SY, Hong JB, Hinnebusch BJ, O’Loughlin JL, Deobald CF, Bohach GA,
Hovde CJ, Minnich SA. 2012. Role of a new intimin/invasin-like protein in
Yersinia pestis virulence. Infect Immun 80:3559–3569. https://doi.org/10
.1128/IAI.00294-12.
6. Lewenza S, Gardy JL, Brinkman FS, Hancock RE. 2005. Genome-wide
identiﬁcation of Pseudomonas aeruginosa exported proteins using a
consensus computational strategy combined with a laboratory-based
PhoA fusion screen. Genome Res 15:321–329. https://doi.org/10.1101/gr
.3257305.
7. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will
O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D,
Olson MV, Manoil C. 2003. Comprehensive transposon mutant library of
Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100:14339–14344.
https://doi.org/10.1073/pnas.2036282100.
8. Mahan MJ, Heithoff DM, Sinsheimer RL, Low DA. 2000. Assessment of
bacterial pathogenesis by analysis of gene expression in the host.
Annu Rev Genet 34:139–164. https://doi.org/10.1146/annurev.genet
.34.1.139.
9. Darwin AJ. 2005. Genome-wide screens to identify genes of human
pathogenic Yersinia species that are expressed during host infection.
Curr Issues Mol Biol 7:135–149.
10. Broome-Smith JK, Spratt BG. 1986. A vector for the construction of
translational fusions to TEM beta-lactamase and the analysis of protein
export signals and membrane protein topology. Gene 49:341–349.
https://doi.org/10.1016/0378-1119(86)90370-7.
11. McCann JR, McDonough JA, Sullivan JT, Feltcher ME, Braunstein M. 2011.
Genome-wide identiﬁcation ofMycobacterium tuberculosis exported pro-
teins with roles in intracellular growth. J Bacteriol 193:854–861. https://
doi.org/10.1128/JB.01271-10.
12. Elofsson A, von Heijne G. 2007. Membrane protein structure: prediction
versus reality. Annu Rev Biochem 76:125–140. https://doi.org/10.1146/
annurev.biochem.76.052705.163539.
13. Flores AR, Parsons LM, Pavelka MS, Jr. 2005. Genetic analysis of the
beta-lactamases of Mycobacterium tuberculosis and Mycobacterium
smegmatis and susceptibility to beta-lactam antibiotics. Microbiology
151:521–532. https://doi.org/10.1099/mic.0.27629-0.
14. Sassetti CM, Rubin EJ. 2003. Genetic requirements for mycobacterial
survival during infection. Proc Natl Acad Sci U S A 100:12989–12994.
https://doi.org/10.1073/pnas.2134250100.
15. Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, Schuster BM,
Trauner A, Wallis D, Galaviz S, Huttenhower C, Sacchettini JC, Behar SM,
Rubin EJ. 2013. Tryptophan biosynthesis protects mycobacteria from
CD4 T-cell-mediated killing. Cell 155:1296–1308. https://doi.org/10
.1016/j.cell.2013.10.045.
16. Lamichhane G, Tyagi S, Bishai WR. 2005. Designer arrays for deﬁned
mutant analysis to detect genes essential for survival of Mycobacterium
Bacterial Proteins Exported during Host Infection ®
March/April 2017 Volume 8 Issue 2 e00333-17 mbio.asm.org 13
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
tuberculosis in mouse lungs. Infect Immun 73:2533–2540. https://doi
.org/10.1128/IAI.73.4.2533-2540.2005.
17. Orme I, Gonzalez-Juarrero M. 2007. Animal models of M. tuberculosis
infection. Curr Protoc Microbiol Chapter 10:Unit 10A.5. https://doi.org/
10.1002/9780471729259.mc10a05s7.
18. Goldberg M, Saini NK, Porcelli SA. 2014. Evasion of innate and adaptive
immunity by Mycobacterium tuberculosis. ASM Press, Washington, DC.
19. Palucci I, Camassa S, Cascioferro A, Sali M, Anoosheh S, Zumbo A,
Minerva M, Iantomasi R, De Maio F, Di Sante G, Ria F, Sanguinetti M, Palu
G, Brennan MJ, Manganelli R, Delogu G. 2016. PE_PGRS33 contributes to
Mycobacterium tuberculosis entry in macrophages through interaction
with TLR2. PLoS One 11:e0150800. https://doi.org/10.1371/journal.pone
.0150800.
20. Bottai D, Stinear TP, Supply P, Brosch R. 2014, Mycobacterial pathog-
enomics and evolution. ASM Press, Washington, DC.
21. Claros MG, von Heijne G. 1994. TopPred II: an improved software for
membrane protein structure predictions. Comput Appl Biosci 10:
685–686.
22. Belardinelli JM, Yazidi A, Yang L, Fabre L, Li W, Jacques B, Angala SK,
Rouiller I, Zgurskaya HI, Sygusch J, Jackson M. 2016. Structure-function
proﬁle of MmpL3, the essential mycolic acid transporter from Mycobac-
terium tuberculosis. ACS Infect Dis 2:702–713. https://doi.org/10.1021/
acsinfecdis.6b00095.
23. Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero
M, Schnappinger D, Jackson M. 2016. Therapeutic potential of the
Mycobacterium tuberculosis mycolic acid transporter, MmpL3. Antimi-
crob Agents Chemother 60:5198–5207. https://doi.org/10.1128/AAC
.00826-16.
24. Li W, Upadhyay A, Fontes FL, North EJ, Wang Y, Crans DC, Grzegorzewicz
AE, Jones V, Franzblau SG, Lee RE, Crick DC, Jackson M. 2014. Novel
insights into the mechanism of inhibition of MmpL3, a target of multiple
pharmacophores in Mycobacterium tuberculosis. Antimicrob Agents Che-
mother 58:6413–6423. https://doi.org/10.1128/AAC.03229-14.
25. Rayasam GV. 2014. MmpL3 a potential new target for development of
novel anti-tuberculosis drugs. Expert Opin Ther Targets 18:247–256.
https://doi.org/10.1517/14728222.2014.859677.
26. Remuiñán MJ, Pérez-Herrán E, Rullás J, Alemparte C, Martínez-Hoyos M,
Dow DJ, Afari J, Mehta N, Esquivias J, Jiménez E, Ortega-Muro F, Fraile-
Gabaldón MT, Spivey VL, Loman NJ, Pallen MJ, Constantinidou C, Minick
DJ, Cacho M, Rebollo-López MJ, González C, Sousa V, Angulo-Barturen I,
Mendoza-Losana A, Barros D, Besra GS, Ballell L, Cammack N. 2013.
Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6=,7=-
dihydrospiro[piperidine-4,4=-thieno[3,2-c]pyran] analogues with bacteri-
cidal efﬁcacy against Mycobacterium tuberculosis targeting MmpL3. PLoS
One 8:e60933. https://doi.org/10.1371/journal.pone.0060933.
27. Poce G, Bates RH, Alfonso S, Cocozza M, Porretta GC, Ballell L, Rullas J,
Ortega F, De Logu A, Agus E, La Rosa V, Pasca MR, De Rossi E, Wae B,
Franzblau SG, Manetti F, Botta M, Biava M. 2013. Improved BM212
MmpL3 inhibitor analogue shows efﬁcacy in acute murine model of
tuberculosis infection. PLoS One 8:e56980. https://doi.org/10.1371/
journal.pone.0056980.
28. Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW,
Walker JR, Alland D, Barry CE, III, Boshoff HI. 2012. SQ109 targets MmpL3,
a membrane transporter of trehalose monomycolate involved in mycolic
acid donation to the cell wall core of Mycobacterium tuberculosis. Anti-
microb Agents Chemother 56:1797–1809. https://doi.org/10.1128/AAC
.05708-11.
29. La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava MR, Raju RM,
Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR,
Sacchettini JC, Manetti F, Botta M, De Logu A, Rubin EJ, De Rossi EJ. 2012.
MmpL3 is the cellular target of the antitubercular pyrrole derivative
BM212. Antimicrob Agents Chemother 56:324–331. https://doi.org/10
.1128/AAC.05270-11.
30. Sandhu P, Akhter Y. 2015. The internal gene duplication and interrupted
coding sequences in the MmpL genes of Mycobacterium tuberculosis:
towards understanding the multidrug transport in an evolutionary per-
spective. Int J Med Microbiol 305:413–423. https://doi.org/10.1016/j
.ijmm.2015.03.005.
31. Varela C, Rittmann D, Singh A, Krumbach K, Bhatt K, Eggeling L, Besra GS,
Bhatt A. 2012. MmpL genes are associated with mycolic acid metabolism
in mycobacteria and corynebacteria. Chem Biol 19:498–506. https://doi
.org/10.1016/j.chembiol.2012.03.006.
32. Ioerger TR, O’Malley T, Liao R, Guinn KM, Hickey MJ, Mohaideen N,
Murphy KC, Boshoff HI, Mizrahi V, Rubin EJ, Sassetti CM, Barry CE, III,
Sherman DR, Parish T, Sacchettini JC. 2013. Identiﬁcation of new drug
targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS
One 8:e75245. https://doi.org/10.1371/journal.pone.0075245.
33. Lamichhane G, Zignol M, Blades NJ, Geiman DE, Dougherty A, Grosset J,
Broman KW, Bishai WR. 2003. A postgenomic method for predicting
essential genes at subsaturation levels of mutagenesis: application to
Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 100:7213–7218.
https://doi.org/10.1073/pnas.1231432100.
34. Danelishvili L, Yamazaki Y, Selker J, Bermudez LE. 2010. Secreted Myco-
bacterium tuberculosis Rv3654c and Rv3655c proteins participate in the
suppression of macrophage apoptosis. PLoS One 5:e10474. https://doi
.org/10.1371/journal.pone.0010474.
35. Perkowski EF, Miller BK, McCann JR, Sullivan JT, Malik S, Allen IC, Godfrey
V, Hayden JD, Braunstein M. 2016. An orphaned Mce-associated mem-
brane protein of Mycobacterium tuberculosis is a virulence factor that
stabilizes Mce transporters. Mol Microbiol 100:90–107. https://doi.org/
10.1111/mmi.13303.
36. Wolfe LM, Mahaffey SB, Kruh NA, Dobos KM. 2010. Proteomic deﬁnition
of the cell wall of Mycobacterium tuberculosis. J Proteome Res
9:5816–5826. https://doi.org/10.1021/pr1005873.
37. Harth G, Lee BY, Wang J, Clemens DL, Horwitz MA. 1996. Novel insights
into the genetics, biochemistry, and immunocytochemistry of the 30-
kilodalton major extracellular protein of Mycobacterium tuberculosis.
Infect Immun 64:3038–3047.
38. Zhao S, Zhao Y, Mao F, Zhang C, Bai B, Zhang H, Shi C, Xu Z. 2012.
Protective and therapeutic efﬁcacy of Mycobacterium smegmatis ex-
pressing HBHA-hIL12 fusion protein against Mycobacterium tuberculosis
in mice. PLoS One 7:e31908. https://doi.org/10.1371/journal.pone
.0031908.
39. Song H, Sandie R, Wang Y, Andrade-Navarro MA, Niederweis M. 2008.
Identiﬁcation of outer membrane proteins of Mycobacterium tuberculo-
sis. Tuberculosis 88:526–544. https://doi.org/10.1016/j.tube.2008.02.004.
40. Speer A, Sun J, Danilchanka O, Meikle V, Rowland JL, Walter K, Buck BR,
Pavlenok M, Hölscher C, Ehrt S, Niederweis M. 2015. Surface hydrolysis of
sphingomyelin by the outer membrane protein Rv0888 supports repli-
cation of Mycobacterium tuberculosis in macrophages. Mol Microbiol
97:881–897. https://doi.org/10.1111/mmi.13073.
41. Saleh MT, Belisle JT. 2000. Secretion of an acid phosphatase (SapM) by
Mycobacterium tuberculosis that is similar to eukaryotic acid phospha-
tases. J Bacteriol 182:6850–6853. https://doi.org/10.1128/JB.182.23.6850
-6853.2000.
42. Nagai S, Wiker HG, Harboe M, Kinomoto M. 1991. Isolation and partial
characterization of major protein antigens in the culture ﬂuid of Myco-
bacterium tuberculosis. Infect Immun 59:372–382.
43. Houben EN, Korotkov KV, Bitter W. 2014. Take ﬁve—type VII secretion
systems of mycobacteria. Biochim Biophys Acta 1843:1707–1716.
https://doi.org/10.1016/j.bbamcr.2013.11.003.
44. Braunstein M, Espinosa B, Chan J, Belisle JT, Jacobs WR, Jr. 2003. SecA2
functions in the secretion of superoxide dismutase A and in the viru-
lence of Mycobacterium tuberculosis. Mol Microbiol 48:453–464.
45. Feltcher ME, Gunawardena HP, Zulauf KE, Malik S, Grifﬁn JE, Sassetti CM,
Chen X, Braunstein M. 2015. Label-free quantitative proteomics reveals
a role for the Mycobacterium tuberculosis SecA2 pathway in exporting
solute binding proteins and Mce transporters to the cell wall. Mol Cell
Proteomics 14:1501–1506. https://doi.org/10.1074/mcp.M114.044685.
46. van der Woude AD, Stoop EJ, Stiess M, Wang S, Ummels R, van
Stempvoort G, Piersma SR, Cascioferro A, Jiménez CR, Houben EN,
Luirink J, Pieters J, van der Sar AM, Bitter W. 2014. Analysis of SecA2-
dependent substrates in Mycobacterium marinum identiﬁes protein ki-
nase G (PknG) as a virulence effector. Cell Microbiol 16:280–295. https://
doi.org/10.1111/cmi.12221.
47. Rosenberger T, Brülle JK, Sander P. 2013. Retraction: a beta-lactamase
based reporter system for ESX dependent protein translocation in my-
cobacteria. PLoS One https://doi.org/10.1371/annotation/f03f7456-0e04
-4c4b-a606-51f262900e8d.
48. Rosenberger T, Brülle JK, Sander P. 2012. A beta-lactamase based re-
porter system for ESX dependent protein translocation in mycobacteria.
PLoS One 7:e35453. https://doi.org/10.1371/journal.pone.0035453.
49. Daleke MH, Ummels R, Bawono P, Heringa J, Vandenbroucke-Grauls CM,
Luirink J, Bitter W. 2012. General secretion signal for the mycobacterial
type VII secretion pathway. Proc Natl Acad Sci U S A 109:11342–11347.
https://doi.org/10.1073/pnas.1119453109.
50. Abdallah AM, Verboom T, Weerdenburg EM, Gey van Pittius NC, Maha-
sha PW, Jiménez C, Parra M, Cadieux N, Brennan MJ, Appelmelk BJ, Bitter
Perkowski et al. ®
March/April 2017 Volume 8 Issue 2 e00333-17 mbio.asm.org 14
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
W. 2009. PPE and PE_PGRS proteins of Mycobacterium marinum are
transported via the type VII secretion system ESX-5. Mol Microbiol
73:329–340. https://doi.org/10.1111/j.1365-2958.2009.06783.x.
51. VanderVen BC, Harder JD, Crick DC, Belisle JT. 2005. Export-mediated
assembly of mycobacterial glycoproteins parallels eukaryotic pathways.
Science 309:941–943. https://doi.org/10.1126/science.1114347.
52. Liu CF, Tonini L, Malaga W, Beau M, Stella A, Bouyssié D, Jackson MC,
Nigou J, Puzo G, Guilhot C, Burlet-Schiltz O, Rivière M. 2013. Bacterial
protein-O-mannosylating enzyme is crucial for virulence of Mycobacte-
rium tuberculosis. Proc Natl Acad Sci U S A 110:6560–6565. https://doi
.org/10.1073/pnas.1219704110.
53. Tusnády GE, Simon I. 2001. The HMMTOP transmembrane topology
prediction server. Bioinformatics 17:849–850. https://doi.org/10.1093/
bioinformatics/17.9.849.
54. Girrbach V, Zeller T, Priesmeier M, Strahl-Bolsinger S. 2000. Structure-
function analysis of the dolichyl phosphate-mannose: protein
O-mannosyltransferase ScPmt1p. J Biol Chem 275:19288–19296. https://
doi.org/10.1074/jbc.M001771200.
55. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL. 2001. Predicting
transmembrane protein topology with a hidden Markov model: appli-
cation to complete genomes. J Mol Biol 305:567–580. https://doi.org/10
.1006/jmbi.2000.4315.
56. Lew JM, Kapopoulou A, Jones LM, Cole ST. 2011. TubercuList—10 years
after. Tuberculosis 91:1–7. https://doi.org/10.1016/j.tube.2010.09.008.
57. Stewart GR, Patel J, Robertson BD, Rae A, Young DB. 2005. Mycobacterial
mutants with defective control of phagosomal acidiﬁcation. PLoS Pat-
hog 1:269–278. https://doi.org/10.1371/journal.ppat.0010033.
58. Rifat D, Karakousis PC. 2014. Differential regulation of the two-component
regulatory system senX3-regX3 in Mycobacterium tuberculosis. Microbiology
160:1125–1133. https://doi.org/10.1099/mic.0.077180-0.
59. Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR, Jr. 2007. The
two-component regulatory system senX3-regX3 regulates phosphate-
dependent gene expression in Mycobacterium smegmatis. J Bacteriol
189:5495–5503. https://doi.org/10.1128/JB.00190-07.
60. Rowland JL, Niederweis M. 2013. A multicopper oxidase is required for
copper resistance in Mycobacterium tuberculosis. J Bacteriol 195:
3724–3733. https://doi.org/10.1128/JB.00546-13.
61. Shi X, Festa RA, Ioerger TR, Butler-Wu S, Sacchettini JC, Darwin KH,
Samanovic MI. 2014. The copper-responsive RicR regulon contributes to
Mycobacterium tuberculosis virulence. mBio 5:e00876-13. https://doi.org/
10.1128/mBio.00876-13.
62. Shi X, Darwin KH. 2015. Copper homeostasis in Mycobacterium tubercu-
losis. Metallomics 7:929–934. https://doi.org/10.1039/c4mt00305e.
63. Coombes BK, Lowden MJ, Bishop JL, Wickham ME, Brown NF, Duong N,
Osborne S, Gal-Mor O, Finlay BB. 2007. SseL is a salmonella-speciﬁc
translocated effector integrated into the SsrB-controlled salmonella
pathogenicity island 2 type III secretion system. Infect Immun 75:
574–580. https://doi.org/10.1128/IAI.00985-06.
64. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. 2005.
Plague bacteria target immune cells during infection. Science 309:
1739–1741. https://doi.org/10.1126/science.1114580.
65. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. 1999.
The Salmonella invasin SipB induces macrophage apoptosis by binding
to caspase-1. Proc Natl Acad Sci U S A 96:2396–2401. https://doi.org/10
.1073/pnas.96.5.2396.
66. Mahdavi A, Szychowski J, Ngo JT, Sweredoski MJ, Graham RL, Hess S,
Schneewind O, Mazmanian SK, Tirrell DA. 2014. Identiﬁcation of secreted
bacterial proteins by noncanonical amino acid tagging. Proc Natl Acad
Sci U S A 111:433–438. https://doi.org/10.1073/pnas.1301740111.
67. Chande AG, Siddiqui Z, Midha MK, Sirohi V, Ravichandran S, Rao KV.
2015. Selective enrichment of mycobacterial proteins from infected host
macrophages. Sci Rep 5:13430. https://doi.org/10.1038/srep13430.
68. Braunstein M, Bardarov SS, Jacobs WR, Jr. 2002. Genetic methods for
deciphering virulence determinants of Mycobacterium tuberculosis.
Methods Enzymol 358:67–99.
69. Pavelka MS, Jr, Jacobs WR, Jr. 1999. Comparison of the construction of
unmarked deletion mutations in Mycobacterium smegmatis, Mycobacte-
rium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis
H37Rv by allelic exchange. J Bacteriol 181:4780–4789.
70. Robbins N, Koch SE, Tranter M, Rubinstein J. 2012. The history and future
of probenecid. Cardiovasc Toxicol 12:1–9. https://doi.org/10.1007/
s12012-011-9145-8.
71. Fraley C, Raftery AE, Murphy TB, Scrucca L. 2012. MCLUST Version 4 for
R: Normal mixture modeling for model-based clustering, classiﬁcation,
and density estimation, Technical Report no. 597, Department of Statis-
tics, University of Washington. http://www.stat.washington.edu/mclust/.
72. Plocinska R, Purushotham G, Sarva K, Vadrevu IS, Pandeeti EV, Arora N,
Plocinski P, Madiraju MV, Rajagopalan M. 2012. Septal localization of the
Mycobacterium tuberculosis MtrB sensor kinase promotes MtrA regulon
expression. J Biol Chem 287:23887–23899. https://doi.org/10.1074/jbc
.M112.346544.
73. Petersen TN, Brunak S, von Heijne G, Nielsen H. 2011. SignalP 4.0:
discriminating signal peptides from transmembrane regions. Nat Meth-
ods 8:785–786. https://doi.org/10.1038/nmeth.1701.
74. Sutcliffe IC, Harrington DJ. 2004. Lipoproteins of Mycobacterium
tuberculosis: an abundant and functionally diverse class of cell envelope
components. FEMS Microbiol Rev 28:645–659. https://doi.org/10.1016/j
.femsre.2004.06.002.
75. McDonough JA, McCann JR, Tekippe EM, Silverman JS, Rigel NW, Braun-
stein M. 2008. Identiﬁcation of functional Tat signal sequences in Myco-
bacterium tuberculosis proteins. J Bacteriol 190:6428–6438. https://doi
.org/10.1128/JB.00749-08.
76. Sullivan JT, Young EF, McCann JR, Braunstein M. 2012. The Mycobacte-
rium tuberculosis SecA2 system subverts phagosome maturation to pro-
mote growth in macrophages. Infect Immun 80:996–1006. https://doi
.org/10.1128/IAI.05987-11.
77. Saleh MT, Fillon M, Brennan PJ, Belisle JT. 2001. Identiﬁcation of putative
exported/secreted proteins in prokaryotic proteomes. Gene 269:
195–204. https://doi.org/10.1016/S0378-1119(01)00436-X.
78. Rifat D, Belchis DA, Karakousis PC. 2014. senX3-independent contribution
of regX3 to Mycobacterium tuberculosis virulence. BMC Microbiol 14:265.
https://doi.org/10.1186/s12866-014-0265-8.
79. Tischler AD, Leistikow RL, Kirksey MA, Voskuil MI, McKinney JD. 2013.
Mycobacterium tuberculosis requires phosphate-responsive gene regula-
tion to resist host immunity. Infect Immun 81:317–328. https://doi.org/
10.1128/IAI.01136-12.
80. Gioffré A, Infante E, Aguilar D, Santangelo MP, Klepp L, Amadio A, Meikle
V, Etchechoury I, Romano MI, Cataldi A, Hernández RP, Bigi F. 2005.
Mutation in mce operons attenuates Mycobacterium tuberculosis viru-
lence. Microbes Infect 7:325–334. https://doi.org/10.1016/j.micinf.2004
.11.007.
81. Sassetti CM, Boyd DH, Rubin EJ. 2003. Genes required for mycobacterial
growth deﬁned by high density mutagenesis. Mol Microbiol 48:77–84.
https://doi.org/10.1046/j.1365-2958.2003.03425.x.
82. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dol-
ganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. 2003. Transcriptional
adaptation ofMycobacterium tuberculosiswithin macrophages: insights into
the phagosomal environment. J Exp Med 198:693–704. https://doi.org/10
.1084/jem.20030846.
83. Chuang YM, Bandyopadhyay N, Rifat D, Rubin H, Bader JS, Karakousis PC.
2015. Deﬁciency of the novel exopolyphosphatase Rv1026/PPX2 leads to
metabolic downshift and altered cell wall permeability inMycobacterium
tuberculosis. mBio 6:e02428. https://doi.org/10.1128/mBio.02428-14.
84. Papavinasasundaram KG, Chan B, Chung JH, Colston MJ, Davis EO,
Av-Gay Y. 2005. Deletion of the Mycobacterium tuberculosis pknH gene
confers a higher bacillary load during the chronic phase of infection in
BALB/c mice. J Bacteriol 187:5751–5760. https://doi.org/10.1128/JB.187
.16.5751-5760.2005.
85. Dubnau E, Chan J, Mohan VP, Smith I. 2005. Responses ofMycobacterium
tuberculosis to growth in the mouse lung. Infect Immun 73:3754–3757.
https://doi.org/10.1128/IAI.73.6.3754-3757.2005.
86. Dutta NK, Mehra S, Didier PJ, Roy CJ, Doyle LA, Alvarez X, Ratterree M, Be
NA, Lamichhane G, Jain SK, Lacey MR, Lackner AA, Kaushal D. 2010.
Genetic requirements for the survival of tubercle bacilli in primates. J
Infect Dis 201:1743–1752. https://doi.org/10.1086/652497.
87. Marjanovic O, Miyata T, Goodridge A, Kendall LV, Riley LW. 2010. Mce2
operon mutant strain of Mycobacterium tuberculosis is attenuated in
C57BL/6 mice. Tuberculosis 90:50–56. https://doi.org/10.1016/j.tube
.2009.10.004.
88. Senaratne RH, Sidders B, Sequeira P, Saunders G, Dunphy K, Marjanovic
O, Reader JR, Lima P, Chan S, Kendall S, McFadden J, Riley LW. 2008.
Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons
are attenuated in mice. J Med Microbiol 57:164–170. https://doi.org/10
.1099/jmm.0.47454-0.
89. Dubnau E, Fontán P, Manganelli R, Soares-Appel S, Smith I. 2002. Myco-
bacterium tuberculosis genes induced during infection of human mac-
rophages. Infect Immun 70:2787–2795. https://doi.org/10.1128/IAI.70.6
.2787-2795.2002.
Bacterial Proteins Exported during Host Infection ®
March/April 2017 Volume 8 Issue 2 e00333-17 mbio.asm.org 15
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
90. Talaat AM, Ward SK, Wu CW, Rondon E, Tavano C, Bannantine JP, Lyons
R, Johnston SA. 2007. Mycobacterial bacilli are metabolically active
during chronic tuberculosis in murine lungs: insights from genome-wide
transcriptional proﬁling. J Bacteriol 189:4265–4274. https://doi.org/10
.1128/JB.00011-07.
91. Rengarajan J, Bloom BR, Rubin EJ. 2005. Genome-wide requirements for
Mycobacterium tuberculosis adaptation and survival in macrophages.
Proc Natl Acad Sci U S A 102:8327–8332. https://doi.org/10.1073/pnas
.0503272102.
92. Rachman H, Strong M, Ulrichs T, Grode L, Schuchhardt J, Mollenkopf H,
Kosmiadi GA, Eisenberg D, Kaufmann SH. 2006. Unique transcriptome
signature of Mycobacterium tuberculosis in pulmonary tuberculosis. In-
fect Immun 74:1233–1242. https://doi.org/10.1128/IAI.74.2.1233-1242
.2006.
93. Hu Y, van der Geize R, Besra GS, Gurcha SS, Liu A, Rohde M, Singh M,
Coates A. 2010. 3-ketosteroid 9alpha-hydroxylase is an essential factor in
the pathogenesis of Mycobacterium tuberculosis. Mol Microbiol 75:
107–121. https://doi.org/10.1111/j.1365-2958.2009.06957.x.
Perkowski et al. ®
March/April 2017 Volume 8 Issue 2 e00333-17 mbio.asm.org 16
 o
n
 Septem
ber 12, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
Erratum for Perkowski et al., “The EXIT
Strategy: an Approach for Identifying
Bacterial Proteins Exported during Host
Infection”
E. F. Perkowski,a* K. E. Zulauf,a D. Weerakoon,a J. D. Hayden,a* T. R. Ioerger,b
D. Oreper,c S. M. Gomez,c J. C. Sacchettini,d M. Braunsteina
Department of Microbiology and Immunology, University of North Carolina—Chapel Hill, Chapel Hill, North
Carolina, USAa; Department of Computer Science and Engineering, Texas A&M University, College Station,
Texas, USAb; Joint Department of Biomedical Engineering at UNC—Chapel Hill and NC State University,
Chapel Hill, North Carolina, USAc; Department of Biochemistry and Biophysics, Texas A&M University, College
Station, Texas, USAd
Volume 8, no. 2, e00333-17, 2017, https://doi.org/10.1128/mBio.00333-17. Wecorrect the following error in our published paper. The sentence in the Discus-
sion (page 9 of the PDF) listing HbhA as one of a set of examples of previously known
exported proteins that we identiﬁed using the EXIT strategy is incorrect. HbhA was not
identiﬁed in our study. This textual error does not impact the ﬁndings or the conclu-
sions of our paper, and it does not change the list of 593 proteins (Table S1) that we
did identify as exported in vivo in our study.
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